Results 31 to 40 of about 1,518 (207)

A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis. [PDF]

Am J Clin Dermatol, 2022
Bissonnette R, Call RS, Raoof T, Zhu Z, Yeleswaram S, Gong X, Lee M.   +6 more
europepmc   +3 more sources

Treatment of refractory Hailey-Hailey disease with oral upadacitinib and topical ruxolitinib 1.5% cream [PDF]

JAAD Case Reports
George Alhwayek, BS, Maggie Sanders, BS, Victoria Farley, MD   +2 more
doaj   +3 more sources

Treatment of vitiligo with topical ruxolitinib: a narrative review [PDF]

Drugs in Context
Vitiligo is a chronic autoimmune disorder characterized by the selective destruction of melanocytes, leading to depigmented patches of skin. Whilst its pathogenesis is not fully understood, genetic predisposition, environmental triggers, oxidative stress,
Gabriela Monteiro e Silva, Adam Mohamed, Cesar Ferreira, Tiago Torres   +3 more
doaj   +2 more sources

Ruxolitinib cream for the treatment of vitiligo [PDF]

The Lancet, 2020
S. K. Uppal, Donovan G. Kearns, Vipawee S. Chat, Jashin J. Wu   +3 more
openalex   +3 more sources

Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis. [PDF]

Am J Clin Dermatol, 2023
Hoy SM.
europepmc   +3 more sources

Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study [PDF]

, 2020
BACKGROUND: Atopic dermatitis (AD), a chronic, highly pruritic skin disorder, impairs quality of life (QoL). Janus kinase inhibitors suppress inflammatory and pruritus-associated cytokine signaling in AD.
Brian Kim, Kang Sun, Kim Papp, May E. Venturanza, Adnan Nasir, Michael E. Kuligowski   +5 more
openalex   +4 more sources

Ruxolitinib Phosphate Cream [PDF]

, 2020
National Cancer Institute
openalex   +2 more sources

Use of Ruxolitinib Cream Results in Economic Benefits Compared with Dupilumab in Treatment of Patients with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy. [PDF]

Dermatol Ther (Heidelb)
Noor O, Liu J, Sturm D, Ren H, Paranagama D, Chiesa Fuxench ZC, Chovatiya R.   +6 more
europepmc   +3 more sources

Case series of topical 1.5% ruxolitinib cream for pediatric vitiligo. [PDF]

JAAD Case Rep
Meister HM, Lebwohl M, Silverberg N.
europepmc   +3 more sources

Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies. [PDF]

Am J Clin Dermatol
Simpson EL, Augustin M, Thaçi D, Misery L, Armstrong AW, Blauvelt A, Papp KA, Szepietowski JC, Boguniewicz M, Kwatra SG, Kallender H, Sturm D, Ren H, Kircik L.   +13 more
europepmc   +3 more sources